Explain this page
Arphra AIPlain-English read on Zimmer Biomet Holdings, Inc.’s valuationStock splits
DB · stock_splits1| Date | Ratio | Type | Multiplier |
|---|---|---|---|
| Mar 01, 2022 | 103-for-100 | Forward | 1.03× |
M&A activity
2DBWhole-company transactions where ZBH is acquirer or target.
Beneficial-ownership filings
DB · 13D/G10| Filed | Form | Reporter | % owned | Shares | |
|---|---|---|---|---|---|
| Nov 14, 2024 | — | 52-0556948 | 7.20% | — | SEC → |
| Feb 14, 2024 | — | 52-0556948 | 4.50% | — | SEC → |
| Feb 13, 2024 | — | Dodge & Cox 94-1441976 | 5.50% | — | SEC → |
| Feb 14, 2023 | — | 52-0556948 | 5.30% | — | SEC → |
| Jan 27, 2023 | — | 13-4151777 | 19.70% | — | SEC → |
| Nov 07, 2022 | — | JPMORGAN CHASE & CO.13-2624428 | 2.40% | — | SEC → |
| Apr 08, 2022 | — | The Vanguard Group - 23-1945930 | 11.04% | — | SEC → |
| Feb 10, 2022 | — | The Vanguard Group - 23-1945930 | 9.29% | — | SEC → |
| Jan 28, 2022 | — | (1) BlackRock, Inc. | 10.40% | — | SEC → |
| Jan 28, 2022 | — | JPMORGAN CHASE & CO.13-2624428 | 5.40% | — | SEC → |
Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.